Silver Book Fact

Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.

Campbell C, Kipnes M, Stouch B, et al. Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy. Pain. 2012; 153(9): 1815-23. http://www.ncbi.nlm.nih.gov/pubmed/22683276

Reference

Title
Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy
Publication
Pain
Publication Date
2012
Authors
Campbell C, Kipnes M, Stouch B, et al
Volume & Issue
Volume 153, Issue 9
Pages
1815-23
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • Statin use in mouse models show pain-alleviating effects for neuropathic pain.